Fertility Services Industry Snapshot
The global Fertility Services market was valued at USD 18.53 billion in 2024 and is set to reach USD 31.16 billion by 2034, growing at a steady CAGR of 5.94%.
Fertility Services is defined as medical care and procedures that enable individuals and couples to overcome their challenges of getting a child. Fertility services involve a myriad of procedures like in vitro fertilization (IVF), freezing eggs, sperm donation, surrogacy, among others. Fertility services are available to both men and women suffering from infertility and are offered by specialty clinics, hospitals, and health practitioners.
The market for fertility services has been continuously on the rise because of reasons such as delayed childbearing, lifestyle, and increasing awareness regarding fertility problems. Advances in technology, higher success rates for treatments, and increased accessibility of fertility services have further pushed the market to grow. Further, increasing societal tolerance towards other means of building a family, such as surrogacy and gay couples opting for reproductive help, has also led to the market's growth. The fertility services market is also aided by continued innovation in the development of more and better treatments, and thus is a fast-growing industry within healthcare.
Fertility Services Market Report Scope
|
Report Attribute
|
Details
|
|
Market Value (2024)
|
USD 18.53 Billion
|
|
Projected Market Value (2034)
|
USD 31.16 Billion
|
|
Base Year
|
2024
|
|
Historical Year
|
2020-2023
|
|
Forecast Years
|
2025 – 2034
|
|
Scope of the Report
|
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Based on By Fertility Treatment Type, By Service Provider, By End-User, By Technology, By Gender, & Region.
|
|
Quantitative Units
|
Revenue in USD million/billion and CAGR from 2025 to 2034.
|
|
Report Coverage
|
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis.
|
|
Delivery Format
|
Delivered as an attached PDF and Excel through email, according to the purchase option.
|
Dynamic Insights
One of the key drivers of market growth is the increasing number of individuals and couples suffering from infertility, thanks to delayed marriages, increased stress levels, and lifestyle factors. This has driven the demand for fertility treatments such as in vitro fertilization (IVF), egg freezing, and assisted reproductive technologies (ART). Another major force propelling the market is ongoing technological advancements in fertility treatments, which have enhanced success rates and made the procedures more accessible and efficient.
These improvements, such as genetic testing and cryopreservation, have facilitated enhanced patient satisfaction and confidence in fertility services. Moreover, increased awareness and acceptance of non-traditional family-building alternatives, including surrogacy and same-sex fertility treatments, have further grown the market. However, high treatment costs, ethical issues with fertility options, and the psychological and physical exhaustion of those receiving these forms of treatment could slow market growth. Nevertheless, the market is vibrant with rising investments from healthcare providers and governments that are empowering the development of the sector.
Core Drivers
The rising global rate of infertility is one of the key drivers of the fertility services market. Various factors are driving this increase, including delayed childbearing as a result of career and lifestyle decisions, as well as medical conditions such as polycystic ovary syndrome (PCOS) and endometriosis, which are increasingly common.
The age at which individuals are choosing to have children is rising, resulting in an increase in cases of infertility. As people and couples turn to medical help to get pregnant, demand for fertility treatment such as in vitro fertilization (IVF), egg freezing, and sperm donation increases, thus driving the market. Increasing awareness of fertility problems and willingness to receive treatment have increased adoption of fertility services considerably.
-
Advancements in Assisted Reproductive Technology (ART)
Technological innovation is a principal driver of the growth of the fertility services market. Developments in assisted reproductive technology (ART), e.g., the refinement of IVF procedures, genetic screening, and cryopreservation techniques, have greatly increased the success rates of fertility treatments. Technologies like genetic testing enable health practitioners to test embryos for genetic disorders and cause healthier pregnancies.
Besides, egg and sperm freezing technology has facilitated fertility preservation for people who wish to postpone childbirth for personal or career purposes. These advances not only deliver improved results for patients but also promote broader application of fertility services by minimizing risks and maximizing treatment success rates.
Market Constraints
-
Emotional and Physical Stress of Treatment
Undergoing fertility treatments can be physically and emotionally demanding. Patients often experience physical discomfort and side effects from hormone treatments, as well as the stress of undergoing invasive procedures like egg retrieval and embryo transfer. The emotional toll, including feelings of frustration, anxiety, and disappointment after unsuccessful cycles, can discourage individuals from continuing treatment. This emotional strain, combined with the physical challenges, may result in many people opting out of fertility treatments after one or more unsuccessful attempts. These factors can limit the overall market potential, as not all individuals are willing or able to endure the demands of fertility services.
-
Ethical and Social Concerns
Ethical and social issues are associated with some fertility treatments, especially genetic testing, surrogacy, and freezing of embryos. Public opinion can be shaped by ethical arguments over the moral status of genetic screening and embryos, constraining the public's acceptance of fertility services. Surrogacy and other reproductive alternatives also generate concerns over surrogates' rights, donors' rights, and the rights of children born via these methods.
Legal and ethical limitations differ between countries, and this may produce a highly regulated environment that can discourage some individuals from accessing fertility services. These issues, although not across the board, present important obstacles in some markets.
Future Potential
-
Increasing Acceptance of Same-Sex Couples and Single Parents Seeking Fertility Services
As societal norms continue to evolve, there is a growing acceptance of same-sex couples and single individuals seeking fertility treatments. This demographic has become an important market segment, as more people explore options like sperm donation, egg donation, and surrogacy to build families. Legal changes and social acceptance of diverse family structures have opened new opportunities for fertility service providers to cater to a wider audience. Expanding services to include these groups, along with specialized care tailored to their unique needs, can significantly boost the market. This trend presents a promising opportunity for growth in the fertility services sector.
Market Segmentation Overview
-
By Fertility Treatment Type
By fertility treatment type, the market includes services such as IVF (In Vitro Fertilization), IUI (Intrauterine Insemination), ICSI (Intracytoplasmic Sperm Injection), surrogacy, and egg/sperm donation. These treatments aim to assist individuals and couples facing infertility issues by providing options for conceiving. IVF and IUI are the most common treatments, with IVF being the most widely recognized.
ICSI, a specialized form of IVF, is used when male infertility is the cause, while surrogacy and egg/sperm donation are used in cases where the biological parents cannot provide viable eggs or sperm. Other treatments may include hormone therapies and less common reproductive techniques, catering to diverse needs.
By service provider, the market for fertility services is segmented into fertility clinics, hospitals, and others. Fertility clinics are specialized medical centers that are committed to offering fertility treatments, usually with sophisticated reproductive technology and experienced fertility specialists. Hospitals can provide fertility services as part of their overall healthcare services, with an emphasis on offering a complete range of treatments, including high-risk cases. Some service providers also cover specialized centers for complementary therapy such as acupuncture or nutrition counseling to further assist patients undergoing fertility treatments.
By end-user, the market for fertility services is segmented into couples, single women, the LGBTQ+ community, and others. Couples, both heterosexual and same-sex, constitute the biggest share of the market, approaching fertility treatments for infertility or inability to conceive. Single women are increasingly seeking fertility services to bear children, often using sperm donation or egg freezing as part of their family formation plans.
The LGBTQ+ population, especially gay couples, is also a large market segment, who in many cases depend on sperm/egg donation, surrogacy, or both to form their families. The "others" segment comprises those who might pursue fertility services for reasons not typically covered by the other segments, like specific medical conditions or non-traditional family-forming alternatives.
Assisted Reproductive Technology (ART) and non-Assisted Reproductive Technology form the market categorized by technology. ART involves therapies such as IVF, ICSI, and cryopreservation, which involve direct facilitation of conception. ART has come as a paradigm shift in treating fertility as it has introduced previously non-existent solutions to fertility problems, and as such, remains a significant driving force in market growth.
Non-assisted reproduction technologies generally refer to less complicated treatments such as medication for stimulating ovulation and natural cycle follow-up, that improve the rates of conception with the help of more complex reproduction procedures. Non-assisted as well as assisted technology addresses disparate sections of population depending on infertility severity and what the individuals or couples desire.
By gender, the fertility services market can be segmented into female, male, and both. Female fertility services focus on addressing infertility issues related to ovulation, egg quality, and other reproductive health factors. Male fertility services are directed toward addressing sperm count, quality, and motility, often using advanced techniques like ICSI to overcome male infertility.
The "both" category refers to treatments that require both male and female participation, such as IVF, where both the sperm and eggs are involved, and surrogacy, where both partners may contribute to the biological aspect of conception. This segmentation highlights the different roles each gender plays in fertility treatments and the growing need for tailored solutions in the fertility industry.
Regional Overview
North America is a huge market for fertility services due to the presence of sophisticated healthcare centers, good awareness of fertility treatments, and comprehensive insurance coverage in nations such as the U.S. and Canada. Access to state-of-the-art assisted reproductive technologies (ART) and favorable legal support for procedures such as surrogacy and egg/sperm donation also contribute to the growth of the market. The trend of increasing delayed childbearing among women in North America is also responsible for the growing demand for fertility services.
In Europe, the market is also experiencing steady growth, with countries like the UK, Spain, and Denmark leading in ART procedures. European countries have strong healthcare systems and, in some cases, government-funded fertility treatments, which make services more accessible. However, there are varying regulations across countries, with some nations offering more comprehensive support than others.
Asia-Pacific is experiencing high growth in the fertility services market, especially in nations such as China, Japan, and India. Increased urbanization, increased disposable incomes, and enhanced awareness regarding infertility treatments make the market expand in this region. In spite of cultural aspects around fertility, more individuals are resorting to ART services as awareness spreads, most importantly in nations that experience high levels of increasing infertility resulting from lifestyle changes.
Middle East and Africa has a smaller but expanding market, fueled by rising adoption of ART treatments in nations such as the UAE and Saudi Arabia. But social and cultural attitudes could impede market growth in some areas. In Latin America, Brazil and Mexico have become major players with increasing demand for IVF and surrogacy services. Fertility tourism is also becoming popular in areas where the treatments are less expensive than in North America and Europe.
Market Player Analysis
Some of the leading market players are fertility clinics such as RMA (Reproductive Medicine Associates), IVF Spain, and CCRM (Colorado Center for Reproductive Medicine), which have established strong brand names for providing innovative assisted reproductive technologies (ART) such as IVF, ICSI, and egg/sperm donation. These companies emphasize utilizing the latest technologies and high success rates to make their products stand out in the market. Most of these firms also possess international networks, serving international patients and providing services like fertility tourism.
Besides large clinics, hospitals and healthcare systems are also an important part of the fertility services market, especially in nations such as the U.S. and UK, where large hospitals provide complete reproductive care. Large healthcare providers such as Providence Health & Services and NHS (National Health Service) provide fertility services along with general healthcare, leveraging their large patient base.
The industry also increasingly has new entrants and specialty players who concentrate on niche services or technology innovation. For example, some specialize in egg freezing or surrogacy services, while others invest in artificial intelligence (AI) or genetic screening technology to enhance ART success rates. In addition, operators in the fertility tourism industry, especially in nations where treatment is cheaper like India, Thailand, and Mexico, are competing more by providing affordable options and quality treatments, drawing foreign patients.
Competitive tactics in the fertility services industry are centered on enhancing patient experience, increasing service offerings, and investing in cutting-edge technologies. Mergers and collaborations between fertility service providers and technology firms are also an emerging trend to increase treatment success rates and service availability. The market is competitive, with a combination of conventional healthcare providers and innovative firms determining its future.
Leading Companies
- Monash IVF
- Merck KGaA
- LABOTECT GMBH
- Fertility Focus Limited
- Carolinas Fertility Institute
- Vitrolife
- Apollo Hospitals Group
- Medicover AB
- The Cooper Companies Inc.
- CooperSurgical, Inc.
- INVO Bioscience
- Olympus Corporation
- Instituto Bernabeu
- VirtusHealth
- Care Fertility
- Vitrolife
Recent Highlights
- In Dec 2024, Femasys, Inc., a prominent biomedical company dedicated to addressing critical unmet needs for women globally through its extensive range of in-office, accessible, and innovative therapeutic and diagnostic products, has announced a partnership with HRC Fertility. As one of the largest and most established providers of IVF and fertility services in the Western U.S., HRC Fertility will now offer Femasys’ FemaSeed Intratubal Insemination as a treatment option for infertility to patients at its California locations.
- In Nov 2024, Rhea, a global reproductive health services company dedicated to enhancing the fertility journey for modern families, has officially launched today. As the first end-to-end reproductive health ecosystem, Rhea connects prospective families in Asia with complementary operations in North America and Europe, offering a high standard of comprehensive care across these regions.
Fertility Services Market Segmentation
By Fertility Treatment Type
- IVF (In Vitro Fertilization)
- IUI (Intrauterine Insemination)
- ICSI (Intracytoplasmic Sperm Injection)
- Surrogacy
- Egg/Sperm Donation
- Others
By Service Provider
- Fertility Clinics
- Hospitals
- Others
By End-User
- Couples
- Single Women
- LGBTQ+ Community
- Others
By Technology
- Assisted Reproductive Technology (ART)
- Non-Assisted Reproductive Technology
By Gender
By Region
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Rest of Asia Pacific
- Middle East & Africa
- South Africa
- Saudi Arabia
- Kuwait
- UAE
- Rest of Middle East & Africa
Objectives of the Study
The study focuses on analyzing the global Fertility Services market through the following key objectives:
- Market Sizing and Forecasting: Estimate the market size and growth for Fertility Services By Fertility Treatment Type, By Service Provider, By End-User, By Technology, By Gender, and Region from 2025 to 2034.
- Market Dynamics and Trends: Analyze key drivers, challenges, and opportunities shaping the market, along with evolving consumer preferences and fashion trends.
- Consumer Insights: Understand factors influencing consumer behavior, including brand perception, sustainability, and regional differences.
- Competitive Landscape: Profile major players with insights into financial performance, product portfolios, SWOT analysis, and strategic initiatives.
- Strategic Recommendations: Identify future trends, technologies, and actionable strategies for stakeholders to drive growth and address challenges effectively.
+1 812 506 4440
+39 3349953425
+91 9270434043
sales@metricwaveinsights.com
Ask For Discount
Enquiry Before Buy
Ask For Customization
